All Studies Meta Analysis

In-silico Approach for Predicting the Inhibitory Effect of Home Remedies on Severe Acute Respiratory Syndrome Coronavirus-2

Thapa et al., Makara Journal of Science, doi:10.7454/mss.v27i3.1609

Sep 2023

Post
Facebook

Source PDF All Studies Meta AnalysisMeta

Curcumin for COVID-19

15th treatment shown to reduce risk in February 2021, now with p = 0.0000000096 from 27 studies.

Lower risk for mortality, ventilation, hospitalization, progression, recovery, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

5,100+ studies for 112 treatments. c19early.org

In Silico analysis showing that curcumin and quercetin may be beneficial for COVID-19 by binding to the main protease (M^pro), spike protein, and ACE2 receptor. Both compounds had suitable ADME properties and minimal predicted toxicity.

51 preclinical studies support the efficacy of curcumin for COVID-19:

26 In Silico studies1-26

24 In Vitro studies1,3,7,9,13,19,23,27-43

1 In Vivo animal study7

In Silico studies predict inhibition of SARS-CoV-2 with curcumin or metabolites via binding to the spikeA,1,2,7,12,14,20,23 (and specifically the receptor binding domainB,10,13,16), M^proC,1,2,7,9,11-13,15,16,18,21,23,24,26,40, RNA-dependent RNA polymeraseD,1,2,13,22, PLproE,2, ACE2F,14,15,17, nucleocapsidG,8,25, nsp10H,25, and helicaseI,29 proteins. In Vitro studies demonstrate inhibition of the spikeA,34 (and specifically the receptor binding domainB,43), M^proC,19,34,40,42, ACE2F,43, and TMPRSS2J,43 proteins, and inhibition of spike-ACE2 interactionK,27. In Vitro studies demonstrate efficacy in Calu-3L,41, A549M,34, 293TN,3, HEK293-hACE2O,19,32, 293T/hACE2/TMPRSS2P,33, Vero E6Q,9,13,23,32,34,36,37,39,41, and SH-SY5YR,31 cells. Curcumin is predicted to inhibit the interaction between the SARS-CoV-2 spike protein receptor binding domain and the human ACE2 receptor for the delta and omicron variants10, decreases pro-inflammatory cytokines induced by SARS-CoV-2 in peripheral blood mononuclear cells39, alleviates SARS-CoV-2 spike protein-induced mitochondrial membrane damage and oxidative stress3, may limit COVID-19 induced cardiac damage by inhibiting the NF-κB signaling pathway which mediates the profibrotic effects of the SARS-CoV-2 spike protein on cardiac fibroblasts28, and inhibits SARS-CoV-2 ORF3a ion channel activity, which contributes to viral pathogenicity and cytotoxicity35.

Important missing comments or errors? Let us know.

Study covers curcumin and quercetin.

1. Al balawi et al., Assessing multi-target antiviral and antioxidant activities of natural compounds against SARS-CoV-2: an integrated in vitro and in silico study, Bioresources and Bioprocessing, doi:10.1186/s40643-024-00822-z.springeropen.com, doi.org.

2. Haque et al., Exploring potential therapeutic candidates against COVID-19: a molecular docking study, Discover Molecules, doi:10.1007/s44345-024-00005-5.springer.com, doi.org.

3. Zhang et al., Computational Discovery of Mitochondrial Dysfunction Biomarkers in Severe SARS-CoV-2 Infection: Facilitating Pytomedicine Screening, Phytomedicine, doi:10.1016/j.phymed.2024.155784.sciencedirect.com, doi.org.

4. Öztürkkan et al., In Silico investigation of the effects of curcuminoids on the spike protein of the omicron variant of SARS-CoV-2, Baku State University Journal of Chemistry and Material Sciences, 1:2, bsuj.bsu.edu.az/uploads/pdf/ec4204d62f7802de54e6092bf7860029.pdf.edu.az.

5. Yunze et al., Therapeutic effect and potential mechanism of curcumin, an active ingredient in Tongnao Decoction, on COVID-19 combined with stroke: a network pharmacology study and GEO database mining, Research Square, doi:10.21203/rs.3.rs-4329762/v1.researchsquare.com, doi.org.

6. Agamah et al., Network-based multi-omics-disease-drug associations reveal drug repurposing candidates for COVID-19 disease phases, ScienceOpen, doi:10.58647/DRUGARXIV.PR000010.v1.scienceopen.com, doi.org.

7. Boseila et al., Throat spray formulated with virucidal Pharmaceutical excipients as an effective early prophylactic or treatment strategy against pharyngitis post-exposure to SARS CoV-2, European Journal of Pharmaceutics and Biopharmaceutics, doi:10.1016/j.ejpb.2024.114279.sciencedirect.com, doi.org.

8. Hidayah et al., Bioinformatics study of curcumin, demethoxycurcumin, bisdemethoxycurcumin and cyclocurcumin compounds in Curcuma longa as an antiviral agent via nucleocapsid on SARS-CoV-2 inhibition, International Conference on Organic and Applied Chemistry, doi:10.1063/5.0197724.aip.org, doi.org.

9. Singh et al., Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 M Pro protein - An in-silico and cell-based approach, Research Square, doi:10.21203/rs.3.rs-3888947/v1.researchsquare.com, doi.org.

10. Kant et al., Structure-based drug discovery to identify SARS-CoV2 spike protein–ACE2 interaction inhibitors, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2023.2300060.tandfonline.com, doi.org.

11. Naderi Beni et al., In silico studies of anti-oxidative and hot temperament-based phytochemicals as natural inhibitors of SARS-CoV-2 Mpro, PLOS ONE, doi:10.1371/journal.pone.0295014.plos.org, doi.org.

12. Moschovou et al., Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein, International Journal of Molecular Sciences, doi:10.3390/ijms242115894.mdpi.com, doi.org.

13. Eleraky et al., Curcumin Transferosome-Loaded Thermosensitive Intranasal in situ Gel as Prospective Antiviral Therapy for SARS-Cov-2, International Journal of Nanomedicine, doi:10.2147/IJN.S423251.dovepress.com, doi.org.

14. Singh (B) et al., Computational studies to analyze effect of curcumin inhibition on coronavirus D614G mutated spike protein, The Seybold Report, doi:10.17605/OSF.IO/TKEXJ.ac.in, doi.org.

15. Thapa et al., In-silico Approach for Predicting the Inhibitory Effect of Home Remedies on Severe Acute Respiratory Syndrome Coronavirus-2, Makara Journal of Science, doi:10.7454/mss.v27i3.1609.ac.id, doi.org.

16. Srivastava et al., Paradigm of Well-Orchestrated Pharmacokinetic Properties of Curcuminoids Relative to Conventional Drugs for the Inactivation of SARS-CoV-2 Receptors: An In Silico Approach, Stresses, doi:10.3390/stresses3030043.mdpi.com, doi.org.

17. Alkafaas et al., A study on the effect of natural products against the transmission of B.1.1.529 Omicron, Virology Journal, doi:10.1186/s12985-023-02160-6.biomedcentral.com, doi.org.

18. Winih Kinasih et al., Analisis in silico interaksi senyawa kurkuminoid terhadap enzim main protease 6LU7 dari SARS-CoV-2, Duta Pharma Journal, doi:10.47701/djp.v3i1.2904.ac.id, doi.org.

19. Wu et al., Potential Mechanism of Curcumin and Resveratrol against SARS-CoV-2, Research Square, doi:10.21203/rs.3.rs-2780614/v1.researchsquare.com, doi.org.

20. Nag et al., Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105552.sciencedirect.com, doi.org.

21. Rampogu et al., Molecular Docking and Molecular Dynamics Simulations Discover Curcumin Analogue as a Plausible Dual Inhibitor for SARS-CoV-2, International Journal of Molecular Sciences, doi:10.3390/ijms23031771.mdpi.com, doi.org.

22. Singh (C) et al., Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104965.sciencedirect.com, doi.org.

23. Kandeil et al., Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2, Pathogens, doi:10.3390/pathogens10060758.mdpi.com, doi.org.

24. Rajagopal et al., Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach, Future Journal of Pharmaceutical Sciences, doi:10.1186/s43094-020-00126-x.springeropen.com, doi.org.

25. Suravajhala et al., Comparative Docking Studies on Curcumin with COVID-19 Proteins, Preprints, doi:10.20944/preprints202005.0439.v3.preprints.org, doi.org.

26. Sekiou et al., In-Silico Identification of Potent Inhibitors of COVID-19 Main Protease (Mpro) and Angiotensin Converting Enzyme 2 (ACE2) from Natural Products: Quercetin, Hispidulin, and Cirsimaritin Exhibited Better Potential Inhibition than Hydroxy-Chloroquine Against COVID-19 Main Protease Active Site and ACE2, ChemRxiv, doi:10.26434/chemrxiv.12181404.v1.chemrxiv.org, doi.org.

27. Emam et al., Establishment of in-house assay for screening of anti-SARS-CoV-2 protein inhibitors, AMB Express, doi:10.1186/s13568-024-01739-8.springeropen.com, doi.org.

28. Van Tin et al., Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-κB Signaling, Cells, doi:10.3390/cells13161331.mdpi.com, doi.org.

29. Li et al., Thermal shift assay (TSA)-based drug screening strategy for rapid discovery of inhibitors against the Nsp13 helicase of SARS-CoV-2, Animals and Zoonoses, doi:10.1016/j.azn.2024.06.001.sciencedirect.com, doi.org.

30. Kamble et al., Nanoparticulate curcumin spray imparts prophylactic and therapeutic properties against SARS-CoV-2, Emergent Materials, doi:10.1007/s42247-024-00754-6.springer.com, doi.org.

31. Nicoliche et al., Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2, Scientific Reports, doi:10.1038/s41598-024-61662-7.nature.com, doi.org.

32. Nittayananta et al., A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity, Virology Journal, doi:10.1186/s12985-023-02282-x.biomedcentral.com, doi.org.

33. Septisetyani et al., Curcumin and turmeric extract inhibited SARS-CoV-2 pseudovirus cell entry and Spike mediated cell fusion, bioRxiv, doi:10.1101/2023.09.28.560070.biorxiv.org, doi.org.

34. Mohd Abd Razak et al., In Vitro Anti-SARS-CoV-2 Activities of Curcumin and Selected Phenolic Compounds, Natural Product Communications, doi:10.1177/1934578X231188861.sagepub.com, doi.org.

35. Fam et al., Channel activity of SARS-CoV-2 viroporin ORF3a inhibited by adamantanes and phenolic plant metabolites, Scientific Reports, doi:10.1038/s41598-023-31764-9.nature.com, doi.org.

36. Teshima et al., Antiviral activity of curcumin and its analogs selected by an artificial intelligence-supported activity prediction system in SARS-CoV-2-infected VeroE6 cells, Natural Product Research, doi:10.1080/14786419.2023.2194647.tandfonline.com, doi.org.

37. Leka et al., In vitro antiviral activity against SARS-CoV-2 of common herbal medicinal extracts and their bioactive compounds, Phytotherapy Research, doi:10.1002/ptr.7463.wiley.com, doi.org.

38. Goc et al., Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants, European Journal of Microbiology and Immunology, doi:10.1556/1886.2021.00022.akjournals.com, doi.org.

39. Marín-Palma et al., Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms, Molecules, doi:10.3390/molecules26226900.mdpi.com, doi.org.

40. Bahun et al., Inhibition of the SARS-CoV-2 3CLpro main protease by plant polyphenols, Food Chemistry, doi:10.1016/j.foodchem.2021.131594.sciencedirect.com, doi.org.

41. Bormann et al., Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro, Viruses, doi:10.3390/v13101914.mdpi.com, doi.org.

42. Guijarro-Real et al., Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity, Foods, doi:10.3390/foods10071503.mdpi.com, doi.org.

43. Goc (B) et al., Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions, PLOS ONE, doi:10.1371/journal.pone.0253489.plos.org, doi.org.

a. The trimeric spike (S) protein is a glycoprotein that mediates viral entry by binding to the host ACE2 receptor, is critical for SARS-CoV-2's ability to infect host cells, and is a target of neutralizing antibodies. Inhibition of the spike protein prevents viral attachment, halting infection at the earliest stage.

b. The receptor binding domain is a specific region of the spike protein that binds ACE2 and is a major target of neutralizing antibodies. Focusing on the precise binding site allows highly specific disruption of viral attachment with reduced potential for off-target effects.

c. The main protease or M^pro, also known as 3CL^pro or nsp5, is a cysteine protease that cleaves viral polyproteins into functional units needed for replication. Inhibiting M^pro disrupts the SARS-CoV-2 lifecycle within the host cell, preventing the creation of new copies.

d. RNA-dependent RNA polymerase (RdRp), also called nsp12, is the core enzyme of the viral replicase-transcriptase complex that copies the positive-sense viral RNA genome into negative-sense templates for progeny RNA synthesis. Inhibiting RdRp blocks viral genome replication and transcription.

e. The papain-like protease (PLpro) has multiple functions including cleaving viral polyproteins and suppressing the host immune response by deubiquitination and deISGylation of host proteins. Inhibiting PLpro may block viral replication and help restore normal immune responses.

f. The angiotensin converting enzyme 2 (ACE2) protein is a host cell transmembrane protein that serves as the cellular receptor for the SARS-CoV-2 spike protein. ACE2 is expressed on many cell types, including epithelial cells in the lungs, and allows the virus to enter and infect host cells. Inhibition may affect ACE2's physiological function in blood pressure control.

g. The nucleocapsid (N) protein binds and encapsulates the viral genome by coating the viral RNA. N enables formation and release of infectious virions and plays additional roles in viral replication and pathogenesis. N is also an immunodominant antigen used in diagnostic assays.

h. Non-structural protein 10 (nsp10) serves as an RNA chaperone and stabilizes conformations of nsp12 and nsp14 in the replicase-transcriptase complex, which synthesizes new viral RNAs. Nsp10 disruption may destabilize replicase-transcriptase complex activity.

i. The helicase, or nsp13, protein unwinds the double-stranded viral RNA, a crucial step in replication and transcription. Inhibition may prevent viral genome replication and the creation of new virus components.

j. Transmembrane protease serine 2 (TMPRSS2) is a host cell protease that primes the spike protein, facilitating cellular entry. TMPRSS2 activity helps enable cleavage of the spike protein required for membrane fusion and virus entry. Inhibition may especially protect respiratory epithelial cells, buy may have physiological effects.

k. The interaction between the SARS-CoV-2 spike protein and the human ACE2 receptor is a primary method of viral entry, inhibiting this interaction can prevent the virus from attaching to and entering host cells, halting infection at an early stage.

l. Calu-3 is a human lung adenocarcinoma cell line with moderate ACE2 and TMPRSS2 expression and SARS-CoV-2 susceptibility. It provides a model of the human respiratory epithelium, but many not be ideal for modeling early stages of infection due to the moderate expression levels of ACE2 and TMPRSS2.

m. A549 is a human lung carcinoma cell line with low ACE2 expression and SARS-CoV-2 susceptibility. Viral entry/replication can be studied but the cells may not replicate all aspects of lung infection.

n. 293T is a human embryonic kidney cell line that can be engineered for high ACE2 expression and SARS-CoV-2 susceptibility. 293T cells are easily transfected and support high protein expression.

o. HEK293-hACE2 is a human embryonic kidney cell line with high ACE2 expression and SARS-CoV-2 susceptibility. Cells have been transfected with a plasmid to express the human ACE2 (hACE2) protein.

p. 293T/hACE2/TMPRSS2 is a human embryonic kidney cell line engineered for high ACE2 and TMPRSS2 expression, which mimics key aspects of human infection. 293T/hACE2/TMPRSS2 cells are very susceptible to SARS-CoV-2 infection.

q. Vero E6 is an African green monkey kidney cell line with low/no ACE2 expression and high SARS-CoV-2 susceptibility. The cell line is easy to maintain and supports robust viral replication, however the monkey origin may not accurately represent human responses.

r. SH-SY5Y is a human neuroblastoma cell line that exhibits neuronal phenotypes. It is commonly used as an in vitro model for studying neurotoxicity, neurodegenerative diseases, and neuronal differentiation.

Thapa et al., 19 Sep 2023, peer-reviewed, 4 authors.

In Silico studies are an important part of preclinical research, however results may be very different in vivo.

This Paper Curcumin All

In-silico Approach for Predicting the Inhibitory Effect of Home In-silico Approach for Predicting the Inhibitory Effect of Home Remedies on Severe Acute Respiratory Syndrome Coronavirus-2 Remedies on Severe Acute Respiratory Syndrome Coronavirus-2

Shankar Thapa, Mahalakshmi Suresha Biradar, Janmajoy Banerjee, Dipanjan Karati

doi:10.7454/mss.v27i3.1609

Severe Acute Respiratory Syndrome Coronavirus-2 is an infectious disease caused by coronavirus and spreads through infected droplets inhalation. For the past 3 years, COVID-19 has become a global threat. Vaccinations are currently available and have FDA approval. During the recent pandemic, people adopted a psychological belief that home remedies (turmeric, ginger, garlic, and coriander) can prevent COVID-19. This research aimed to predict the covid-19 inhibitory activities by home remedies through an in-silico approach. The 24 bioactive constituents of four home remedies plants were

References

Ali, Kasry, Amin, The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant, Med. Drug Discov, doi:10.1016/j.medidd.2021.100086

Alkhamees, Alrashed, Alzunaydi, Almohimeed, Aljohani, The psychological impact of COVID-19 pandemic on the general population of Saudi Arabia, Compr. Psychiatry, doi:10.1016/j.comppsych.2020.152192

Barati, Pouresmaieli, Ekrami, Asghari, Ziarani et al., Potential drugs and remedies for the treatment of COVID-19: a Critical review, Biol. Proced. Online, doi:10.1186/s12575-020-00129-1

Barretto, Jukneliene, Ratia, Chen, Mesecar et al., The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity, J. Virol, doi:10.1128/JVI.79.24.15189-15198.2005

Beigel, Tomashek, Dodd, Mehta, Zingman et al., Remdesivir for the Treatment of Covid-19-Final Report, N. Engl. J. Med, doi:10.1056/NEJMoa2007764

Bhokardankar, Rathi, Khan, Rathi, COVID-19 pandemic: Home remedies for immunity boosting, Int. J. Res. Pharm. Sci

Boopathi, Poma, Kolandaivel, Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment, J. Biomol. Struct. Dyn, doi:10.1080/07391102.2020.1758788

Chan, Dorosky, Sharma, Abbasi, Dye et al., Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2, Science, doi:10.1126/science.abc0870

Ciotti, Ciccozzi, Terrinoni, Jiang, Wang et al., The COVID-19 pandemic, Crit. Rev. Clin. Lab. Sci, doi:10.1080/10408363.2020.1783198

Dousari, Moghadam, Satarzadeh, COVID-19 (Coronavirus disease 2019): A New coronavirus disease, Infect. Drug Resist, doi:10.2147/IDR.S259279

Drwal, Banerjee, Dunkel, Wettig, Preissner, ProTox: A web server for the in silico prediction of rodent oral toxicity, Nucleic. Acids Res, doi:10.1093/nar/gku401

Ekins, Mottin, Ramos, Sousa, Neves et al., Stimulating open drug discovery for SARS-CoV-2, Drug Discov. Today, doi:10.1016/j.drudis.2020.03.019

Fan, Fu, Zhang, Progress in molecular docking, Quant. Biol

Filimonov, Lagunin, Gloriozova, Rudik, Druzhilovskii et al., prediction of the biological activity spectra of organic compounds using the pass online web resource, Chem. Heterocycl. Compd, doi:10.1007/s10593-014-1496-1

Ghosh, Tripathi, Talukdar, Talaptara, In silico study by using ProTox-II webserver for oral acute toxicity, organ toxicity, immunotoxicity, genetic toxicity endpoints, nuclear receptor signalling and stress response pathways of synthetic pyrethroids, World Sci. News

Gupta, Pharmacological properties and traditional therapeutic uses of important Indian spices: A Review, Int. J. Food Prop, doi:10.1080/10942910902963271

Islam, Ferdousi, Shahinozzaman, Previously published ethno-pharmacological reports reveal the potentiality of plants and plantderived products used as traditional home remedies by Bangladeshi COVID-19 patients to combat SARS-CoV-2, Saudi J. Biol. Sci, doi:10.1016/j.sjbs.2021.07.036

Jafarzadeh, Jafarzadeh, Nemati, Therapeutic potential of ginger against COVID-19: Is there enough evidence?, J. Tradit. Chinese Med. Sci

Jin, Du, Xu, Deng, Liu et al., Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors, Nature, doi:10.1038/s41586-020-2223-y

Joshi, Joshi, Sharma, Mathpal, Pundir et al., In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking, Eur. Rev. Med. Pharmacol. Sci, doi:10.26355/eurrev_202004_21036

Kannan, Spratt, Cohen, Naqvi, Chand et al., Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses, J. Autoimmun

Kumar, Doshi, Khan, Rathore, COVID-19 pandemic: mechanism, diagnosis, and treatment, J. Chem. Technol. Biotechnol, doi:10.1002/jctb.6641

Li, Moore, Vasilieva, Sui, Wong et al., Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, doi:10.1038/nature02145

Lipinski, Lombardo, Dominy, Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev

Luthra, Singh, Chandra, Therapeutic uses of curcuma longa (turmeric), Indian J. Clin. Biochem, doi:10.1007/BF02864854

Majeed, Hussain, Yasmin, Akhtar, Rasool, Virtual screening of phytochemicals by targeting HR1 domain of SARS-CoV-2 S protein: Molecular docking, molecular dynamics simulations, and DFT studies, Biomed. Res. Int, doi:10.1155/2021/6661191

Majumder, Mandal, Screening of plantbased natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach, J. Biomol. Struct. Dyn, doi:10.1080/07391102.2020.1817787

Moghadamtousi, Kadir, Hassandarvish, Tajik, Abubakar et al., A review on antibacterial, antiviral, and antifungal activity of curcumin, Biomed. Res. Int, doi:10.1155/2014/186864

Nag, Banerjee, Chowdhury, Venkatesh, Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study, VirusDisease, doi:10.1007/s13337-021-00654-x

Negi, Bala, Natural home remedies may act as potential immunomodulatore to protect against SARS-COV-2 infection, J. Exp. Biol. Agric. Sci, doi:10.18006/2020.8(Spl-1-SARS-CoV-2).S176.S189

Niranjan, Prakash, Chemical constituents and biological activities of turmeric (Curcuma longa L.)-A review, J. Food Sci. Technol

Nur, Azam, Al Mahamud, Hasan, Jahan et al., Some home remedies used In-silico Approach for Predicting the Inhibitory Effect 207, J Med Plants Stud

Orisakwe, Orish, Nwanaforo, Coronavirus disease (COVID-19) and Africa: Acclaimed home remedies, Sci. African, doi:10.1016/j.sciaf.2020.e00620

Pham, Nguyen, Tam, Vu, Pham et al., Improving Ligand-Ranking of AutoDock Vina by Changing the Empirical Parameters, J. Comput. Chem, doi:10.1002/jcc.26779

Pillaiyar, Manickam, Namasivayam, Hayashi, Jung, An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy, J. Med. Chem, doi:10.1021/acs.jmedchem.5b01461

Prati, Mancini, The psychological impact of COVID-19 pandemic lockdowns: a review and meta-analysis of longitudinal studies and natural experiments, Psychol. Med, doi:10.1017/S0033291721000015

Rabie, CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy, Mol. Divers, doi:10.1007/s11030-020-10169-0

Rathinavel, Palanisamy, Palanisamy, Subramanian, Thangaswamy, Phytochemical 6-Gingerol-A promising Drug of choice for COVID-19, Int. J. Adv. Sci. Eng, doi:10.29294/IJASE.6.4.2020.1482-1489

Rothan, Byrareddy, The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak, J. Autoimmun, doi:10.1016/j.jaut.2020.102433

Rouf, Uddin, Sarker, Islam, Ali et al., Antiviral potential of garlic (Allium sativum) and its organosulfur compounds: A systematic update of pre-clinical and clinical data, Trends Food Sci. Technol, doi:10.1016/j.tifs.2020.08.006

Roy, Singh, Mishra, Chinnadurai, Mitra et al., Mental health implications of COVID-19 pandemic and its response in India, Int. J. Soc. Psychiatry

Seeliger, De Groot, Ligand docking and binding site analysis with PyMOL and Autodock/Vina, J. Comput. Aided Mol. Des, doi:10.1007/s10822-010-9352-6

Semwal, Chauhan, Kumar, Aswal, Semwal et al., Status of Indian medicinal plants in the international union for conservation of nature and the future of Ayurvedic drugs: Shouldn't think about Ayurvedic fundamentals?, J. Integr. Med, doi:10.1016/j.joim.2019.04.008

Shaker, Yu, Lee, Lee, Jung et al., User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation, J. Microbiol, doi:10.1007/s12275-020-9563-z

Singh, Chauhan, Pandit, Sinha, Gupta et al., The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins, J. Tradit. Complem. Med, doi:10.1016/j.jtcme.2021.09.001

Singh, Kumar, Jyoti, Kumar, Spices and herbs: Potential antiviral preventives and immunity boosters during COVID-19, Phyther. Res, doi:10.1002/ptr.7019

Singletary, Coriander: Overview of potential health benefits, Nutr. Today, doi:10.1097/NT.0000000000000159

Tesfaye, Mengesha, traditional uses , phytochemistry and pharmacological properties of garlic (Allium sativum) and its biological active compounds, Int. J. Sci. Res. Sci. Eng. Technol

Thapa, Nargund, Biradar, Banerjee, Karati, In-silico investigation and drug likeliness studies of benzimidazole congeners: The new face of innovation, Inform. Med. Unlocked

Thapa, Nargund, Biradar, Molecular design and In-Silico analysis of trisubstituted benzimidazole derivatives as ftsz inhibitor, J. Chem, doi:10.1155/2023/9307613

Thapa, Nargund, Biradar, Yadav, Mishra, A Respiratory review on Covid-19: Pathophysiology, diagnosis, treatment, and prevention, J. Biomed. Pharm. Res

Thapa, None, J. Sci

Towler, Staker, Prasad, Menon, Tang et al., ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis, J. Biol. Chem, doi:10.1074/jbc.M311191200

Trott, Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem

Umashankar, Deshpande, Hegde, Singh, Chattopadhyay, Phytochemical moieties from Indian traditional medicine for targeting dual hotspots on SARS-CoV-2 spike protein: An Integrative in-silico approach, Front. Med, doi:10.3389/fmed.2021.672629

Xiong, Wu, Yi, Fu, Yang et al., ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties, Nucleic. Acids Res, doi:10.1093/nar/gkab255

Zarei, Ramazani, Pourmand, Sattari, Rezaei et al., In silico evaluation of COVID-19 main protease interactions with honeybee natural products for discovery of high potential antiviral compounds, Nat. Prod. Res, doi:10.1080/14786419.2021.1974435

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0